secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0000950170-24-097556
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics hires Brett Pletcher as EVP, Chief Legal Officer effective Aug 19, 2024
--------------------------------------------------------------------------------

- Annual base salary $560,000; target bonus 45% of base under Bonus Plan.
- Signing bonus $100,000, repayable if resignation or termination for cause within 12 months.
- Initial equity: ~$1.89M RSUs, ~$1.89M option grant, and performance stock units with $833,520 target value.
- Vesting: RSUs 40/40/20 over 3 years; options 25% cliff then monthly, PSUs vest over 2 years after certification.
- Pletcher was Of Counsel at Gunderson Dettmer; prior EVP, General Counsel at Gilead Sciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017024097556/0000950170-24-097556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017024097556/cytk-20240813.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-097556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer